Trials / Active Not Recruiting
Active Not RecruitingNCT04962607
Effectiveness of Premixed Bioactive Bioceramic MTA (Neo-Putty®) in Pulpotomies Primary Teeth
Effectiveness of Premixed Bioactive Bioceramic MTA (Neo-Putty®) Versus Formocresol as Dressing Agents in Pulpotomized Primary Molars
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 2 Years – 10 Years
- Healthy volunteers
- Accepted
Summary
The objective of this prospective randomized clinical trial is to assess clinically and radiographically, the effect of NeoPutty as a pulp medicament following coronal pulp amputation in human primary molars with carious pulp exposure in comparison to Formocresol (FC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Neo-Putty® as dressing agents in pulpotomized primary molars | Following removal of the coronal pulp with a round bur and hemostasis, the pulp stumps in the study group will be covered with Neo-Putty ® according to the manufacturer's instructions. Neo-Putty will be placed in the prepared cavity, and then covered with Vitrebond® and with a reinforced Zinc Oxide-Eugenol (IRM, Bayer-Leverkussen, Germany). In the control group, a cotton pellet moistened with full-strength FC will be placed for 5 minutes on the amputated pulp, after reaching hemostasis. The pulp stumps will be then covered by IRM |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2021-07-15
- Last updated
- 2025-06-13
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04962607. Inclusion in this directory is not an endorsement.